BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28648120)

  • 1. Long-QT syndrome-associated caveolin-3 mutations differentially regulate the hyperpolarization-activated cyclic nucleotide gated channel 4.
    Motloch LJ; Larbig R; Darabi T; Reda S; Motloch KA; Wernly B; Lichtenauer M; Gebing T; Schwaiger A; Zagidullin N; Wolny M; Hoppe UC
    Physiol Int; 2017 Jun; 104(2):130-138. PubMed ID: 28648120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long QT syndrome caveolin-3 mutations differentially modulate K
    Tyan L; Foell JD; Vincent KP; Woon MT; Mesquitta WT; Lang D; Best JM; Ackerman MJ; McCulloch AD; Glukhov AV; Balijepalli RC; Kamp TJ
    J Physiol; 2019 Mar; 597(6):1531-1551. PubMed ID: 30588629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-3 associates with and affects the function of hyperpolarization-activated cyclic nucleotide-gated channel 4.
    Ye B; Balijepalli RC; Foell JD; Kroboth S; Ye Q; Luo YH; Shi NQ
    Biochemistry; 2008 Nov; 47(47):12312-8. PubMed ID: 19238754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability.
    Campostrini G; Bonzanni M; Lissoni A; Bazzini C; Milanesi R; Vezzoli E; Francolini M; Baruscotti M; Bucchi A; Rivolta I; Fantini M; Severi S; Cappato R; Crotti L; J Schwartz P; DiFrancesco D; Barbuti A
    Cardiovasc Res; 2017 Aug; 113(10):1256-1265. PubMed ID: 28898996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Analyses of Novel HCN4 Gene Mutations.
    Möller M; Silbernagel N; Wrobel E; Stallmayer B; Amedonu E; Rinné S; Peischard S; Meuth SG; Wünsch B; Strutz-Seebohm N; Decher N; Schulze-Bahr E; Seebohm G
    Cell Physiol Biochem; 2018; 49(3):1197-1207. PubMed ID: 30196304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of caveolin 3 protein with the potassium inward rectifier channel Kir2.1: physiology and pathology related to long qt syndrome 9 (LQT9).
    Vaidyanathan R; Vega AL; Song C; Zhou Q; Tan BH; Berger S; Makielski JC; Eckhardt LL
    J Biol Chem; 2013 Jun; 288(24):17472-80. PubMed ID: 23640888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of CAV3 in long-QT syndrome: clinical and functional assessment of a caveolin-3/Kv11.1 double heterozygote versus caveolin-3 single heterozygote.
    Hedley PL; Kanters JK; Dembic M; Jespersen T; Skibsbye L; Aidt FH; Eschen O; Graff C; Behr ER; Schlamowitz S; Corfield V; McKenna WJ; Christiansen M
    Circ Cardiovasc Genet; 2013 Oct; 6(5):452-61. PubMed ID: 24021552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and functional evidence of HCN4 and caveolin-3 interaction during cardiomyocyte differentiation from human embryonic stem cells.
    Bosman A; Sartiani L; Spinelli V; Del Lungo M; Stillitano F; Nosi D; Mugelli A; Cerbai E; Jaconi M
    Stem Cells Dev; 2013 Jun; 22(11):1717-27. PubMed ID: 23311301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation in S6 domain of HCN4 channel in patient with suspected Brugada syndrome modifies channel function.
    Biel S; Aquila M; Hertel B; Berthold A; Neumann T; DiFrancesco D; Moroni A; Thiel G; Kauferstein S
    Pflugers Arch; 2016 Oct; 468(10):1663-71. PubMed ID: 27553229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome.
    Vatta M; Ackerman MJ; Ye B; Makielski JC; Ughanze EE; Taylor EW; Tester DJ; Balijepalli RC; Foell JD; Li Z; Kamp TJ; Towbin JA
    Circulation; 2006 Nov; 114(20):2104-12. PubMed ID: 17060380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pacemaker activity of the human sinoatrial node: effects of HCN4 mutations on the hyperpolarization-activated current.
    Verkerk AO; Wilders R
    Europace; 2014 Mar; 16(3):384-95. PubMed ID: 24569893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src tyrosine kinase alters gating of hyperpolarization-activated HCN4 pacemaker channel through Tyr531.
    Li CH; Zhang Q; Teng B; Mustafa SJ; Huang JY; Yu HG
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C355-62. PubMed ID: 17977941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol potentiates hyperpolarization-activated cyclic nucleotide-gated (HCN4) channels.
    Page DA; Ruben PC
    J Gen Physiol; 2024 Jun; 156(6):. PubMed ID: 38652080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Channel HCN4 mutation R666Q associated with sporadic arrhythmia decreases channel electrophysiological function and increases protein degradation.
    Wang H; Wu T; Huang Z; Huang J; Geng Z; Cui B; Yan Y; Zhang Y; Wang Y
    J Biol Chem; 2022 Nov; 298(11):102599. PubMed ID: 36244448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-associated HCN4 V759I variant is not sufficient to impair cardiac pacemaking.
    Erlenhardt N; Kletke O; Wohlfarth F; Komadowski MA; Clasen L; Makimoto H; Rinné S; Kelm M; Jungen C; Decher N; Meyer C; Klöcker N
    Pflugers Arch; 2020 Dec; 472(12):1733-1742. PubMed ID: 33095298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart.
    Stieber J; Herrmann S; Feil S; Löster J; Feil R; Biel M; Hofmann F; Ludwig A
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15235-40. PubMed ID: 14657344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HCN4 channel mutation D553N associated with bradycardia has a C-linker mediated gating defect.
    Netter MF; Zuzarte M; Schlichthörl G; Klöcker N; Decher N
    Cell Physiol Biochem; 2012; 30(5):1227-40. PubMed ID: 23075627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Novel HCN4 Blockers with Unique Blocking Kinetics and Binding Properties.
    Nakashima K; Nakao K; Matsui H
    SLAS Discov; 2021 Aug; 26(7):896-908. PubMed ID: 34041946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutant HCN4 channel in a family with bradycardia, left bundle branch block, and left ventricular noncompaction.
    Yokoyama R; Kinoshita K; Hata Y; Abe M; Matsuoka K; Hirono K; Kano M; Nakazawa M; Ichida F; Nishida N; Tabata T
    Heart Vessels; 2018 Jul; 33(7):802-819. PubMed ID: 29349559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel gain-of-function mechanism in K(+) channel-related long-QT syndrome: altered gating and selectivity in the HERG1 N629D mutant.
    Lees-Miller JP; Duan Y; Teng GQ; Thorstad K; Duff HJ
    Circ Res; 2000 Mar; 86(5):507-13. PubMed ID: 10720411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.